California Bill Proposes Psychedelic Assisted Therapy Workgroup

California recently failed at least twice in passing sweeping statewide psychedelic decriminalization bills: a) SB-58, which Governor Gavin Newsom vetoed last year, and b) SB-519, which didn’t garner enough support in the assembly the year before. It’s now trying something much more modest – convening a workgroup to study psychedelic assisted therapy.

The bill at issue is AB-941. Assembly Member Marie Waldron originally proposed the bill last year as a bill to authorize licensed counselors to administer psychedelic assisted therapy. However, the bill was nearly completely rewritten in early January 2024 to both convene a workgroup, and to delay the original proposals until the legislature enacts a regulatory framework.

The parameters of the workgroup would be to study and make recommendations on creating a regulatory framework for psychedelic assisted therapy for psilocybin, ibogaine, and other controlled substances approved by the FDA. More specifically, the bill requires the workgroup to study at least the following subjects:

(1) Research on the safety and efficacy of using each of the controlled substances specified [above] in a therapeutic setting for treating post-traumatic stress disorder, depression, anxiety, addiction, and other mental health conditions.

(2) Long-term impact of supervised psychedelic or dissociative drug use with seeking and misusing other substances, including alcohol, cannabis, illicit substances, and unregulated psychedelic or dissociative drugs.

(3) Perceptions of harm of psychedelic or dissociative drugs following enactment of decriminalization both on a personal use and therapeutic use level.

(4) Impact of different regulatory frameworks on different health outcomes among vulnerable populations, including people with substance use disorders, and minority or disenfranchised groups.

(5) Regulated use models for the controlled substances specified [above] from other jurisdictions.

(6) Content and scope of educational campaigns that have proven effective in accurate public health approaches regarding use, effect, and risk reduction for the substances specified [above], including, but not limited to, public service announcements, educational curricula, appropriate crisis response, and appropriate training for first responders and multiresponders, including law enforcement, emergency medical services, fire service, and unarmed coresponder units.

(7) Policies for minimizing use-related risks, including information related to appropriate use and impacts of detrimental substance use.

(8) Appropriate frameworks to govern the therapeutic use of controlled substances, including qualifications and training for therapists or facilitators.

“Subsequent to the Legislature’s adoption of a framework governing psychedelic-assisted therapy using the substances described [above], it is the intent of the Legislature that the transfer of a substance described [above], without financial gain, in the context of psychedelic-assisted therapy, be decriminalized.”